Philippe Huot
Papers
2
Total Citations
17
H-Index
2
About
Philippe Huot is a leading researcher in movement disorders, with a primary focus on Parkinson’s disease and its complications, particularly levodopa-induced dyskinesia (LID). His work bridges preclinical neuroscience and clinical translation, aiming to develop both pharmacological and non-pharmacological interventions for LID. Huot’s major contributions include pioneering the use of frameless stereotaxic robotic injections in common marmosets, a technique that enables precise co-registration of MRI, CT, and PET imaging for targeted brain interventions—a methodological advance cited 13 times. He has also systematically reviewed clinical trial databases to assess emerging therapies for LID, highlighting the promise of non-dopaminergic approaches like the 5-HT1A/1B agonist zolmitriptan and robot-assisted repetitive transcranial magnetic stimulation (rTMS) of the pre-supplementary motor area. His work is characterized by a translational focus, from refining animal models to evaluating clinical trial outcomes. With a growing citation impact, Huot is recognized for advancing the understanding and treatment of dyskinesia, offering new hope for improved quality of life in Parkinson’s patients.
Research Focus
Key Achievements
Top Papers
- 1
- 2